DEVELOPMENT OF HEMICHANNEL-TARGETING ANTIBODY THERAPIES FOR BREAST CANCER BONE METASTASIS
$3,240,958FY2017Department of the ArmyDOD
The University Of Texas Health Science Center At San Antonio
The University Of Texas Health Science Center At San Antonio